A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
Not Applicable
- Conditions
- Peripheral Vascular Disease
- Interventions
- Device: Elecsys®proBNP
- Registration Number
- NCT00519961
- Lead Sponsor
- Hoffmann-La Roche
- Brief Summary
The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1800
Inclusion Criteria
- Adult patients, ≥18 years of age
- Patients with peripheral vascular atherosclerosis, scheduled for vascular surgery
Exclusion Criteria
- N/A
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description A Elecsys®proBNP - B Elecsys®proBNP -
- Primary Outcome Measures
Name Time Method Collection of 30-day and 1-year postoperative cardiac events 30-day and 1-year postoperation
- Secondary Outcome Measures
Name Time Method